Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

ConditionsMuscle-Invasive Bladder Carcinoma Muscle Invasive Bladder Urothelial Carcinoma Bladder Cancer TNM Staging Bladder Cancer Stage IIa Bladder Cancer Stage IIb Bladder Cancer Stage IV Bladder Leiomyosarcoma Bladder Cancer Bladder Cancer Stage II Bladder Cancer Stage IIIa Bladder Cancer Stage IIIb Bladder Cancer Stage IIIc Bladder Urothelial Carcinoma Progression, Disease Urinary Diversion Neobladder Radical Cystectomy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorIRCCS San Raffaele

About this trial

Observational study on the quality of life and pathological state of patients underwent radical cystectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

subjects underwent radical cystectomy

> 18 years old

Ability to read and sign the informed consent

Disqualifiers

Age <18 years

Inability to read and sign the informed consent

Trial population

Patients with muscle-invasive bladder cancer underwent radycal cystectomy

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Radical Cystectomy
Procedure/Surgery
A radical cystectomy is an operation to remove the whole bladder

Treatment groups

4,000 Participants

are divided into 1 treatment group

Group A: Patients underwent radical cystectomy1 intervention

Trial outcomes

Primary outcomes

obtain health benefit for the patients themselves and for future patients underwent radical cystectomy

All patients, before underwent radical cystectomy, receive a diary in which we ask a detailed clinical history of the patient with their symptoms, diagnosis and previous urological e non urological treatments performed before the operation. A detailed intraoperative, postoperative and follow-up clinical history.

Time frame

Baseline and Follow-up. 1 Annual follow-up until the patient decides to stop providing follow-up responses or until the date of death from any cause.

improve the patient's scientific knowledge and develop new procedures for the diagnosis and treatment of the patient

Through the collection of a detailed clinical history of the patient in which themselves report symptoms, diagnosis and previous urological and non-urological treatments and also through the medical record.

Time frame

Baseline and Follow-up. 1 Annual follow-up until the patient decides to stop providing follow-up responses or until the date of death from any cause.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS San Raffaele

Lead sponsor

Source ClinicalTrials.gov

Apply now